Covid-19 Pandemic
 Here’s the latest news from the global pandemic. Republicans plan scaled-back proposal for virus relief bill German virus flare-up fuels fears about European resurgenceJapanese central bank refuses work-from-home requests Don’t Expect a Silver Bullet Enthusiasm is growing for a coronavirus vaccine, but the recent upbeat news about trials and government stockpiling may be fueling a dangerous misperception. A Covid shot won’t be a panacea, and the first approvals won’t mean the end of the outbreak. We’ve seen this before. Everyone thought a period of social distancing and quarantining at home this spring would lead to a summer as usual. They were caught unaware when large parties, packed bars and more in-person activities led to a surge in cases. They hadn’t fully gotten the message that the spring shutdown was done mainly to avert overwhelming hospitals – which was critical – and not as a short-term solution that would put the outbreak in the rear-view mirror. Similarly, the advent of a coronavirus vaccine won’t allow the world to return to normal. For those longing to get back to the office or attend indoor concerts, an immunization that reaches the market at the end of 2020 or early 2021 won’t be a silver bullet.  A vial with a potential Covid-19 vaccine at Novavax labs in Gaithersburg, Maryland Photographer: ANDREW CABALLERO-REYNOLDS/AFP Not everyone will be able to get a shot immediately. High-risk individuals and front-line workers, such as those in health care, will be first. Widespread access will have to wait. Experts expect it won’t offer universal protection or reach nearly the 97% effectiveness rate of the standard two doses of a measles vaccine. They’re hoping it will come close to the 67% protection offered on average by the flu shot. Even that might be a stretch. Anthony Fauci, who is leading the infectious-disease response as part of the White House Coronavirus Task Force, has said 50% protection would be considered a success. And even if you’re able to get the vaccine, you’ll still have to take precautions around high-risk individuals. The ultimate goal is herd immunity. That will require 60% to 80% of people to have some form of protection, from an immunization or a previous infection. If a vaccine gives that to half of those who get it, it will take some time for natural infections to get the world to levels needed for widespread protection. A vaccine won’t be like Willy Wonka’s golden ticket. But it may be like Dorothy’s yellow brick road, offering all of us a path back home. It’s not clear yet where that road begins.—Michelle Fay Cortez Latest podcast The Shadow Over College Athletics Angelica LaVito reports that a new complication is casting a shadow over college athletics, and creating questions about what the disease does to young people.  Sponsored Content by Siemens America’s factories, power plants, transportation and hospitals all need technology and our technology is only as powerful as the people deploying and maintaining it. Keeping America moving takes more than technology alone. It takes a human touch. Siemens Ingenuity for life. What you should read Vaccine Turns Into Shot at Redemption for Britain Finding the Holy Grail would be the ultimate prize after a torrid few months. Workplace Covid Outbreaks Hit Minorities Harder A quarter of workers in Utah study are non-White but have 73% of cases. Super-Yachts Ditch Spain for Croatia and Turkey With renewed restrictions, the ultra-rich flee some traditional mooring spots. Europe Bike Boom Boosts Top Producer Portugal Bicycles have become increasingly popular during the Covid pandemic. Singapore’s Lessons for Post-Lockdown Dining Virus shut some restaurants, but others learned to thrive amid adversity. Know someone else who would like this newsletter? Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg’s Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022 |
PreviousCovid-19 Pandemic